Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2012. Key results include:
For the full year, total revenues increased 11 percent to $17,265 million, with 9 percent product sales growth driven by strong performance across the portfolio. Adjusted EPS grew 22 percent to $6.51 due to 15 percent adjusted operating income growth and lower shares outstanding. PR Newswire (http://s.tt/1yRgA)
